Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19
NCT ID: NCT04397588
Last Updated: 2020-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2020-04-21
2020-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objectives are to describe the characteristics of COVID-19 patients who have received ECMO support, to identify the risk factors associated with hospital mortality, to analyze the outcomes after ECMO weaning including survival at day 28 and day 90, and to analyze the utility of a circulatory support mobile unit in a severe pandemic
Inclusions are both prospective and retrospective in order to collect data over the whole pandemic
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tested positive by RT-PCR for SARS-CoV2 (nasopharyngeal swabs, sputum, endotracheal aspiration, bronchoalveolar lavage or stool sample) and / or with a diagnosis made on chest CT findings,
* Supported by venovenous or venoarterial ECMO
Exclusion Criteria
* Patients or proxies who express their opposition to study participation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas Nesseler, doctor
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
André Vincentelli, professor
Role: PRINCIPAL_INVESTIGATOR
Lille University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angers University Hospital
Angers, , France
Besançon Hospital
Besançon, , France
Brest university Hospital
Brest, , France
Caen University Hospital
Caen, , France
Clermont ferrand University hospital
Clermont-Ferrand, , France
APHP Henri Mondor Paris University Hospital
Créteil, , France
Dijon University Hospital
Dijon, , France
Vendée Hospital
La Roche-sur-Yon, , France
Grenoble University Hospital
La Tronche, , France
APHP Kremli Bicetre Paris University Hospital
Le Kremlin-Bicêtre, , France
Marie Lannelongue Hospital
Le Plessis-Robinson, , France
Lens Hospital
Lens, , France
Lille University Hospital
Lille, , France
Limoges University Hospital
Limoges, , France
Clinique de la Sauvegarde
Lyon, , France
Lyon University Hospital
Lyon, , France
Marseille Européen Hospital
Marseille, , France
APHM la Timone- Marseille University Hospital
Marseille, , France
Clairval Hospital
Marseille, , France
Metz University Hospital
Metz, , France
Montpellier University Hospital
Montpellier, , France
Emile Muller Hospital
Mulhouse, , France
Nancy University Hospital
Nancy, , France
Nantes University Hospital
Nantes, , France
Ambroise Paré Hospital
Neuilly-sur-Seine, , France
Nimes University Hospital
Nîmes, , France
Institut Mutualiste Montsouris
Paris, , France
APHP Hopital Européen Georges Pompidou - Paris University Hospital
Paris, , France
APHP necker Paris University Hospital
Paris, , France
APHP Bichat - Paris University Hospital
Paris, , France
APHP La Pitié Salpêtrière Paris University Hospital
Paris, , France
Bordeaux University Hospital
Pessac, , France
Poitiers University hospital
Poitiers, , France
Reims University hospital
Reims, , France
Rennes University hospital
Rennes, , France
Rouen University Hospital
Rouen, , France
Saint brieuc Hospital
Saint-Brieuc, , France
La Réunion University Hospital
Saint-Denis, , France
Saint Etienne University Hospital
Saint-Etienne, , France
Saint Nazaire Hospital
Saint-Nazaire, , France
Strasbourg University Hospital
Strasbourg, , France
Toulouse University Hospital - Rangueil Hospital
Toulouse, , France
Tours University Hospital
Tours, , France
Bretagne Atlantique Hospital
Vannes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Olivier Fouquet, Doctor
Role: primary
Guillaume Flicoteaux, Doctor
Role: primary
Olivier Huet, professor
Role: primary
Marc-Olivier FISCHER, Professor
Role: primary
Nicolas D'OSTREVY, Doctor
Role: primary
Nicolas Mongardon, Doctor
Role: primary
Pierre Guinot, Doctor
Role: primary
Gwenhaël COLIN, Doctor
Role: primary
Lucie Gaide-chevronnay, Doctor
Role: primary
Jordi Matiello, Doctor
Role: primary
Olaf Mercier, professor
Role: primary
Olivier Fabre, Doctor
Role: primary
André Vincentelli, Professor
Role: primary
Jerome Jouan, Doctor
Role: primary
Olivier DESEBBE, Doctor
Role: primary
Jean-Luc. Fellahi, Professor
Role: primary
Matthias CASTANIER, doctor
Role: primary
Alizée Porto, Doctor
Role: primary
Charles Chanavaz
Role: primary
Cyril Cadoz, Doctor
Role: primary
Philippe Gaudard, Doctor
Role: primary
Nicolas BISCHOFF, Doctor
Role: primary
Bruno Levy, Professor
Role: primary
Bertrand Rozec, Doctor
Role: primary
Stéphane Aubert, Doctor
Role: primary
Claire Roger, Doctor
Role: primary
Kais Brini, Doctor
Role: primary
Bernard Cholley, Professor
Role: primary
Claudio Barbanti, Doctor
Role: primary
Sophie Provenchère, Doctor
Role: primary
Guillaume Lebreton
Role: primary
Alexandre OUATTARA, Professor
Role: primary
Corentin Lacroix, Doctor
Role: primary
Vito Giovanni Ruggieri, Professor
Role: primary
Nicolas Nesseler, Doctor
Role: primary
Emmanuel Besnier, Doctor
Role: primary
Pierre Fillatre, Doctor
Role: primary
Nicolas Allou, Doctor
Role: primary
Roxane NICOLAS
Role: primary
Maud Jonas
Role: primary
Pierre-Emmanuel Falcoz, Professor
Role: primary
François Labaste, Doctor
Role: primary
Antoine Guillon, Doctore
Role: primary
Yannick Fedun, Doctor
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Nesseler N, Mansour A, Schmidt M, Para M, Porto A, Falcoz PE, Mongardon N, Fougerou C, Ross JT, Beurton A, Gaide-Chevronnay L, Guinot PG, Lebreton G, Flecher E, Vincentelli A, Massart N; ECMOSARS Investigators; SFAR Research Network. Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study. Crit Care. 2024 Feb 20;28(1):54. doi: 10.1186/s13054-024-04832-3.
Massart N, Guervilly C, Mansour A, Porto A, Flecher E, Esvan M, Fougerou C, Fillatre P, Duburcq T, Lebreton G, Para M, Stephan F, Hraiech S, Ross JT, Schmidt M, Vincentelli A, Nesseler N; Extracorporeal Membrane Oxygenation for Respiratory Failure and/or Heart failure related to Severe Acute Respiratory Syndrome Coronavirus 2 (ECMOSARS) Investigators. Impact of Prone Position in COVID-19 Patients on Extracorporeal Membrane Oxygenation. Crit Care Med. 2023 Jan 1;51(1):36-46. doi: 10.1097/CCM.0000000000005714. Epub 2022 Nov 11.
Mansour A, Flecher E, Schmidt M, Rozec B, Gouin-Thibault I, Esvan M, Fougerou C, Levy B, Porto A, Ross JT, Para M, Manganiello S, Lebreton G, Vincentelli A, Nesseler N; ECMOSARS Investigators. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study. Intensive Care Med. 2022 Aug;48(8):1039-1052. doi: 10.1007/s00134-022-06794-y. Epub 2022 Jul 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35RC20_8979 ECMO-SARS
Identifier Type: -
Identifier Source: org_study_id